Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew T Roe

Showing results (181-190 of 467) with videos related to

Pageof 47
Sort By:
Circulation. Cardiovascular Quality and Outcomes|June 1, 2018
Neighborhood Socioeconomic Disadvantage and Care After Myocardial Infarction in the National Cardiovascular Data RegistryJacob A Udell, Nihar R Desai, Shuang Li, et al.
American Heart Journal|March 21, 2016
A randomized trial to compare the safety of rivaroxaban vs aspirin in addition to either clopidogrel or ticagrelor in acute coronary syndrome: The design of the GEMINI-ACS-1 phase II studyThomas J Povsic, Matthew T Roe, Erik Magnus Ohman, et al.
Circulation. Cardiovascular Quality and Outcomes|August 11, 2017
Utilization, Characteristics, and In-Hospital Outcomes of Coronary Artery Bypass Grafting in Patients With ST-Segment-Elevation Myocardial Infarction: Results From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The GuidelinesYi Pi, Matthew T Roe, DaJuanicia N Holmes, et al.
American Heart Journal|July 31, 2013
Long-term outcomes among older patients with non-ST-segment elevation myocardial infarction complicated by cardiogenic shockAkshay Bagai, Anita Y Chen, Tracy Y Wang, et al.
The American Journal of Medicine|August 7, 2007
Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarctionChadwick D Miller, Matthew T Roe, Jyotsna Mulgund, et al.
American Heart Journal|June 4, 2014
Prevalence and predictors of nonobstructive coronary artery disease identified with coronary angiography in contemporary clinical practiceManesh R Patel, David Dai, Adrian F Hernandez, et al.
American Heart Journal|April 30, 2013
Incorporation of bleeding as an element of the composite end point in clinical trials of antithrombotic therapies in patients with non-ST-segment elevation acute coronary syndrome: validity, pitfalls, and future approachesSumeet Subherwal, E Magnus Ohman, Kenneth W Mahaffey, et al.
Archives of Internal Medicine|August 13, 2008
Medical records and quality of care in acute coronary syndromes: results from CRUSADEShannon M Dunlay, Karen P Alexander, Chiara Melloni, et al.
American Heart Journal|January 6, 2005
Clinical trial--derived risk model may not generalize to real-world patients with acute coronary syndromeAndrew T Yan, Philip Jong, Raymond T Yan, et al.
The American Journal of Cardiology|May 29, 2004
Combined assessment of thrombolysis in myocardial infarction flow grade, myocardial perfusion grade, and ST-segment resolution to evaluate epicardial and myocardial reperfusionRobert P Giugliano, Marc S Sabatine, C Michael Gibson, et al.
Pageof 47

Showing results (181-190 of 467) with videos related to

Sort By:
Pageof 47
Circulation. Cardiovascular Quality and Outcomes|June 1, 2018
Neighborhood Socioeconomic Disadvantage and Care After Myocardial Infarction in the National Cardiovascular Data RegistryJacob A Udell, Nihar R Desai, Shuang Li, et al.
American Heart Journal|March 21, 2016
A randomized trial to compare the safety of rivaroxaban vs aspirin in addition to either clopidogrel or ticagrelor in acute coronary syndrome: The design of the GEMINI-ACS-1 phase II studyThomas J Povsic, Matthew T Roe, Erik Magnus Ohman, et al.
Circulation. Cardiovascular Quality and Outcomes|August 11, 2017
Utilization, Characteristics, and In-Hospital Outcomes of Coronary Artery Bypass Grafting in Patients With ST-Segment-Elevation Myocardial Infarction: Results From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The GuidelinesYi Pi, Matthew T Roe, DaJuanicia N Holmes, et al.
American Heart Journal|July 31, 2013
Long-term outcomes among older patients with non-ST-segment elevation myocardial infarction complicated by cardiogenic shockAkshay Bagai, Anita Y Chen, Tracy Y Wang, et al.
The American Journal of Medicine|August 7, 2007
Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarctionChadwick D Miller, Matthew T Roe, Jyotsna Mulgund, et al.
American Heart Journal|June 4, 2014
Prevalence and predictors of nonobstructive coronary artery disease identified with coronary angiography in contemporary clinical practiceManesh R Patel, David Dai, Adrian F Hernandez, et al.
American Heart Journal|April 30, 2013
Incorporation of bleeding as an element of the composite end point in clinical trials of antithrombotic therapies in patients with non-ST-segment elevation acute coronary syndrome: validity, pitfalls, and future approachesSumeet Subherwal, E Magnus Ohman, Kenneth W Mahaffey, et al.
Archives of Internal Medicine|August 13, 2008
Medical records and quality of care in acute coronary syndromes: results from CRUSADEShannon M Dunlay, Karen P Alexander, Chiara Melloni, et al.
American Heart Journal|January 6, 2005
Clinical trial--derived risk model may not generalize to real-world patients with acute coronary syndromeAndrew T Yan, Philip Jong, Raymond T Yan, et al.
The American Journal of Cardiology|May 29, 2004
Combined assessment of thrombolysis in myocardial infarction flow grade, myocardial perfusion grade, and ST-segment resolution to evaluate epicardial and myocardial reperfusionRobert P Giugliano, Marc S Sabatine, C Michael Gibson, et al.
Pageof 47